Xiangjiao Meng
- Oncology top 1%
- Lung Cancer Research Studies 32
- Cancer Immunotherapy and Biomarkers 25
- Colorectal Cancer Surgical Treatments 10
- Immunology top 2%
-
- Lung Cancer Treatments and Mutations 35
- Lung Cancer Diagnosis and Treatment 15
- Brain Metastases and Treatment 8
- Cancer Research top 5%
-
- Neuroendocrine Tumor Research Advances 12
-
- Colorectal and Anal Carcinomas 11
- Partner nations
- ChinaUnited StatesSouth Sudan
In The Last Decade
Xiangjiao Meng
98 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 1.9k
- Immunology 956
- Pulmonary and Respiratory Medicine 734
- Cancer Research 313
- Radiology, Nuclear Medicine and Imaging 383
Countries citing papers authored by Xiangjiao Meng
This map shows the geographic impact of Xiangjiao Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangjiao Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangjiao Meng more than expected).
Fields of papers citing papers by Xiangjiao Meng
This network shows the impact of papers produced by Xiangjiao Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangjiao Meng. The network helps show where Xiangjiao Meng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiangjiao Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 9 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 15 | |
| 10 | 2023 | 0 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 9 | |
| 13 | 2021 | 24 | |
| 14 | 2020 | 10 | |
| 15 | 2019 | 26 | |
| 16 | 2017 | 366 | |
| 17 | 2016 | 45 | |
| 18 | 2015 | 105 | |
| 19 | 2014 | 18 | |
| 20 | 2009 | 1 |
About Xiangjiao Meng
Xiangjiao Meng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 106 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (35 papers), Lung Cancer Research Studies (32 papers), Cancer Immunotherapy and Biomarkers (25 papers), Lung Cancer Diagnosis and Treatment (15 papers), Neuroendocrine Tumor Research Advances (12 papers), Colorectal and Anal Carcinomas (11 papers), Colorectal Cancer Surgical Treatments (10 papers) and Brain Metastases and Treatment (8 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (956 citations) and Pulmonary and Respiratory Medicine (734 citations). Xiangjiao Meng has collaborated with scholars based in China, United States and South Sudan. Frequent co-authors include Jinming Yu, Feifei Teng, Zhaoqin Huang, Ligang Xing, Jinming Yu, Li Kong, Li Ren Kong, Liufu Deng, Yingtang Zhou and Dianbin Mu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.